Ken-ichiro Kamei,
Associate Professor, Institute for Integrated Cell-Material Sciences (WPI-iCeMS),
Kyoto University
Ken-ichiro Kamei is an Associate Professor and Principal Investigator at WPI-iCeMS, Kyoto University, where he joined as a faculty member in 2010. He obtained his doctorate in Engineering from Tokyo Institute of Technology in 2003. During 2003-2006, he worked as a Postdoctoral Fellow at the Molecular Biology Institute, University of California, Los Angeles (UCLA). In 2006, he was promoted to Staff Research Associate at the California NanoSystems Institute (CNSI), UCLA (along with Prof. H. R. Tseng). He has developed microfluidic platforms for the phenotypic analysis of human PSCs and in vitro cancer diagnosis. His current research interests focus on the development of “Body on a Chip” platforms to recapitulate in vivo physiological conditions by integrating micro/nano-technology and stem cell biology.
Reverse Bioengineering for Precision Medicine
Wednesday, 19 June 2019 at 14:30
Add to Calendar ▼2019-06-19 14:30:002019-06-19 15:30:00Europe/LondonReverse Bioengineering for Precision MedicineOrgan-on-a-Chip and Tissue-on-a-Chip Europe 2019 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
One of the ultimate goals of bioengineering is to re-create natural living systems by means of synthetic biology and tissue engineering. The long-term mission of our laboratory is to recapitulate the in vivo human physiology and pathology on a microfluidic device, such as “Organs-on-a-Chip” (OoC) or “Microphysiological Systems” (MPSs). Indeed, due to their capacity to recapitulate in vivo physiological and pathological conditions, OOC/MPSs exhibit great potential as alternatives for pre-clinical animal tests to assess drug efficacy and safety. Although several chips and systems have been reported in the last decade, there are still some important issues that need to be addressed; these include: 1) the use of functional tissue cells derived from human pluripotent stem cell (hPSC), 2) the alternatives of polydimethylsiloxane (PDMS) to prevent chemical absorption (in collaboration with USHIO Inc.), and 3) the integration of in situ monitoring systems to monitor cellular responses. Here, our interdisciplinary approach of stem cell biology, material science, and micro/nano-engineering will be introduced to address the aforementioned issues involved in drug discovery and precision medicine.
Add to Calendar ▼2019-06-18 00:00:002019-06-19 00:00:00Europe/LondonOrgan-on-a-Chip and Tissue-on-a-Chip Europe 2019Organ-on-a-Chip and Tissue-on-a-Chip Europe 2019 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
Add to Calendar ▼2019-06-19 14:30:002019-06-19 15:30:00Europe/LondonReverse Bioengineering for Precision MedicineOrgan-on-a-Chip and Tissue-on-a-Chip Europe 2019 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
